Roche First-Quarter Sales Drop on Franc’s Strength, Avastin

[guest]

Roche Holding AG, the world's biggest maker of cancer drugs, said first-quarter sales declined 9 percent as the Swiss franc strengthened and revenue from the Avastin tumor medicine fell.


More...

Toggle signature
||||| Mentor Group Access Now! |||||